FDA Investigator Jaqueline Diaz Albertini
Jaqueline Diaz Albertini has inspections in 1 countries as of 23 Jun 2023. Jaqueline Diaz Albertini has collaborated with a combined 552 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
1
Last Inspection Date:
23 Jun 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
Belgium
Co-Investigator(s):
Anissa M Cheung,
Burnell M Henry,
Christian D Lynch (CDL),
Cynthia Jim, CSO,
Dino Feigelstock (DF), PhD,
Dr. Gang Wang, PhD,
Gene D Arcy,
Haruhiko Murata,
Jacqueline Mdiaz Albertini,
James C Maclaughlin,
John M Mcinnis,
Kirsten L Vadheim, PhD,
LCDR Debra Emerson,
Leslie D Wagner,
Mihaly S Ligmond,
Olno Folgolstock,
Omotunde O Osunsanmi,
Pankaj H Amin,
Paula A Trost,
Pote Amin,
Rebecca K Olin,
Robin Levis, PhD,
Roger F Zabinski,
Rose M Ashley,
Sean R Bryd,
Shuang Tang,
Sidney B Priesmeyer,
Susan M Jackson,
Tina S Roecklein,
Zhihao Qiu (Peter), PhD
Jaqueline Diaz Albertini's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2008 | FDA 483 Response | GlaxoSmithKline Biologicals SA - Form 483R, 2008-06-25 |
June, 2008 | FDA 483 | GlaxoSmithKline Biologicals SA - Form 483, 2008-06-25 |
June, 2008 | EIR | GlaxoSmithKline Biologicals SA - EIR, 2008-06-25 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more